BIONOMICS LIMITED/FI (Form: 6-K, Received: 01/09/2023 06:12:37)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of January, 2023

(Commission File No. 001-41157)

BIONOMICS LIMITED

(Translation of registrant’s name into English)

200 Greenhill Road

Eastwood SA 5063

Tel: +618 8150 7400

(Address of registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

Yes ☐ No ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

Yes ☐ No ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On January 09, 2023, the Company lodged a Notification of Director's Initial Interest for Spyros Papapetropoulos on Appendix 3X, and a Notification of Cessation of Securities in relation to the expiry of unlisted options under the Company's employee incentive plan on Appendix 3H, with the Australian Securities Exchange (ASX) as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts with the Company. The notifications are furnished herewith as Exhibits 99.1 and 99.2 to this report on Form 6-K.

EXHIBIT INDEX



Exhibit	Description
99.1	Director's Initial Interest - Appendix 3X - Spyros
99.2	Expiry of Unlisted Options - Appendix 3H

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.



	Bionomics Limited
	(Registrant)

	By:	/s/ Errol De Souza
	Name:	Errol De Souza, Ph.D.
	Title:	Non-Executive Chairman

Date: January 09, 2023

Exhibit 99.1

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity                BIONOMICS LIMITED

ABN                                    075 582 740

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.


Name of Director	Spyridon Papapetropoulos
Date of appointment	5 January 2023

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities
 
Nil

+ See chapter 19 for defined terms.

11/3/2002 Appendix 3X Page 1

Appendix 3X

Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest
Note: Provide details of the circumstances giving rise to the relevant interest.

Number & class of Securities
 
Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.


Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
No. and class of securities to which interest relates	N/A

+ See chapter 19 for defined terms.

Appendix 3X Page 2 11/3/2002

Exhibit 99.2


	Notification of cessation of +securities

Announcement Summary

Entity name

BIONOMICS LIMITED

Announcement Type
New announcement

Date of this announcement
Monday January 09, 2023

Details of +securities that have ceased

Number of

ASX +security +securities that The +securities have Date of

code Security description have ceased ceased due to cessation

BNOAO	OPTION EXPIRING
VARIOUS DATES EX VARIOUS PRICES
BNOAO	OPTION EXPIRING
VARIOUS DATES EX VARIOUS PRICES
BNOAO	OPTION EXPIRING
VARIOUS DATES EX VARIOUS PRICES
BNOAO	OPTION EXPIRING
VARIOUS DATES EX VARIOUS PRICES
BNOAO	OPTION EXPIRING
VARIOUS DATES EX VARIOUS PRICES

200,000 Expiry of option or other convertible security without exercise or conversion
4,000 Expiry of option or other convertible security without exercise or conversion
5,000 Expiry of option or other convertible security without exercise or conversion
100,000 Expiry of option or other convertible security without exercise or conversion
50,000 Expiry of option or other convertible security without exercise or conversion

Refer to next page for full details of the announcement

Exhibit 99.2

Notification of cessation of +securities 1 / 6

Exhibit 99.2


	Notification of cessation of +securities

Part 1 - Announcement Details

1.1 Name of +Entity
BIONOMICS LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type ABN

1.3 ASX issuer code BNO

1.4 The announcement is

New announcement

Registration Number

53075582740

1.5 Date of this announcement 9/1/2023

Notification of cessation of +securities 2 / 6

Exhibit 99.2


	Notification of cessation of +securities

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
200,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

11/12/2022

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of options under employee incentive scheme to non-KMP members

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
4,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

17/12/2022

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of options under employee incentive scheme to non-KMP members

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
5,000

Notification of cessation of +securities 3 / 6

Exhibit 99.2

Notification of cessation of +securities

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

18/12/2022

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of options under employee incentive scheme to non-KMP members

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
100,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of options under employee incentive scheme to non-KMP members

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
50,000

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

Date of cessation

24/12/2022

Is the entity paying any consideration for the cessation?

Date of cessation

30/12/2022

Is the entity paying any consideration for the cessation?

Any other information the entity wishes to notify to ASX about the cessation?

Expiry of options under employee incentive scheme to non-KMP members

Notification of cessation of +securities 4 / 6

Exhibit 99.2


	Notification of cessation of +securities

Notification of cessation of +securities 5 / 6

Exhibit 99.2


	Notification of cessation of +securities

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

Total number of

ASX +security code and description +securities on issue

BNO : ORDINARY FULLY PAID 1,468,735,424

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

Total number of

ASX +security code and description +securities on issue

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 85,689,567

BNOAS : WARRANTS 142,000,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities 6 / 6